CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$55.57 -0.43 (-0.77%)
As of: Sep 30, 2026 · 9:40 AM EDT

CRISPR Therapeutics AG (CRSP) Operating Expenses (2015 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) posted Operating Expenses of $127.45 million for Q2 2026, down 44.6% from $230.22 million a year earlier and down 3.2% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Operating Expenses (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at CRISPR Therapeutics AG was $547.73 million, down 7.2% year-over-year; for FY2025, it came in at $668.08 million, up 32.6% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of 13.5% (FY2020 to FY2025).
  • In prior years, CRISPR Therapeutics AG's Operating Expenses was $503.88 million in FY2024 (-15.1%), $593.74 million in FY2023 (-12.0%), $674.36 million in FY2022 (+24.6%) and $541.44 million in FY2021 (+52.5%).
  • The Q2 2026 figure stands as the lowest quarterly Operating Expenses since Q4 2024.
  • On a year-over-year basis, Operating Expenses increased in four of the last eight quarters, with growth averaging 4.5%.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q4 2025, with growth of 55.2%; the weakest was Q2 2026, with a decline of 44.6%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $131.71 million (Q1 2026), $155.63 million (Q4 2025) and $132.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 CRISPR Therapeutics AG 5.23 Bn 5.23 Bn - 127.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.45 Mn
Mar 31, 2026 131.71 Mn
Dec 31, 2025 155.63 Mn
Sep 30, 2025 132.95 Mn
Jun 30, 2025 230.22 Mn
Mar 31, 2025 149.29 Mn
Dec 31, 2024 100.28 Mn
Sep 30, 2024 110.73 Mn
Jun 30, 2024 151.78 Mn
Mar 31, 2024 141.09 Mn
Dec 31, 2023 131.62 Mn
Sep 30, 2023 132.41 Mn
Jun 30, 2023 165.22 Mn
Mar 31, 2023 164.49 Mn
Dec 31, 2022 131.55 Mn
Sep 30, 2022 182.48 Mn
Jun 30, 2022 183.42 Mn
Mar 31, 2022 176.91 Mn
Dec 31, 2021 158.60 Mn
Sep 30, 2021 129.67 Mn
API Access

CRISPR Therapeutics AG Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CRSP&period=max&api_key=YOUR_API_KEY